Kymera Therapeutics, Inc.

Report date
3/31/2026
Quarter
2026 Q1
Filed
5/15/2026
Shares
8,657,242
Value ($000)
721,062
Weight
4.1%
2020 Q3 - 2026 Q1 (23 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).